Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0024 | 0.0666 | 0.5 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0666 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0384 | 0.2642 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0019 | 0.0384 | 0.3665 |
Giardia lamblia | DINP protein human, muc B family | 0.0019 | 0.0384 | 0.5 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0666 | 1 |
Brugia malayi | TAR-binding protein | 0.0064 | 0.3205 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0019 | 0.0384 | 0.3665 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0019 | 0.0384 | 0.0347 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0064 | 0.3205 | 0.2934 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | unspecified product | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0019 | 0.0384 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Brugia malayi | RNA binding protein | 0.0064 | 0.3205 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0384 | 0.0347 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0666 | 0.5 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0282 | 0.139 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0666 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0666 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0282 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0064 | 0.3205 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0064 | 0.3205 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0666 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0282 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0019 | 0.0384 | 0.5 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0666 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0666 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0019 | 0.0384 | 0.2642 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0019 | 0.0384 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0282 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0666 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0064 | 0.3205 | 0.2934 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0666 | 0.1313 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0666 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0064 | 0.3205 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0019 | 0.0384 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0024 | 0.0666 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0024 | 0.0666 | 0.1001 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Schistosoma mansoni | tar DNA-binding protein | 0.0064 | 0.3205 | 0.2934 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0024 | 0.0666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0019 | 0.0384 | 1 |
Echinococcus multilocularis | geminin | 0.0171 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0064 | 0.3205 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.